These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
311 related articles for article (PubMed ID: 31749811)
1. Regulation of the Immune Balance During Allogeneic Hematopoietic Stem Cell Transplantation by Vitamin D. Flamann C; Peter K; Kreutz M; Bruns H Front Immunol; 2019; 10():2586. PubMed ID: 31749811 [TBL] [Abstract][Full Text] [Related]
2. Metabolic Targets for Improvement of Allogeneic Hematopoietic Stem Cell Transplantation and Graft-vs.-Host Disease. Tijaro-Ovalle NM; Karantanos T; Wang HT; Boussiotis VA Front Immunol; 2019; 10():295. PubMed ID: 30891031 [TBL] [Abstract][Full Text] [Related]
3. The Role of Co-stimulatory/Co-inhibitory Signals in Graft-vs.-Host Disease. Kumar S; Leigh ND; Cao X Front Immunol; 2018; 9():3003. PubMed ID: 30627129 [TBL] [Abstract][Full Text] [Related]
4. Non-myeloablative hematopoietic stem cell transplantation (NST) in the treatment of human malignancies: from animal models to clinical practice. Shimoni A; Nagler A Cancer Treat Res; 2002; 110():113-36. PubMed ID: 11908195 [TBL] [Abstract][Full Text] [Related]
5. Modeling the interaction between donor-derived regulatory T cells and effector T cells early after allogeneic hematopoietic stem cell transplantation. Nishiyama N; Ruoff P; Jimenez JC; Miwakeichi F; Nishiyama Y; Yata T Biosystems; 2023 May; 227-228():104889. PubMed ID: 37019377 [TBL] [Abstract][Full Text] [Related]
6. [Immune tolerance induced by cytokines in allogeneic hematopoietic stem cell transplantation]. Chang YJ; Huang XJ Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Apr; 41(2):208-11. PubMed ID: 19377632 [TBL] [Abstract][Full Text] [Related]
7. Strategies for Enhancing and Preserving Anti-leukemia Effects Without Aggravating Graft-Versus-Host Disease. Chang YJ; Zhao XY; Huang XJ Front Immunol; 2018; 9():3041. PubMed ID: 30619371 [TBL] [Abstract][Full Text] [Related]
8. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy. Talmadge JE Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168 [TBL] [Abstract][Full Text] [Related]
9. Vitamin D Modifies the Incidence of Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation Depending on the Vitamin D Receptor (VDR) Polymorphisms. Carrillo-Cruz E; García-Lozano JR; Márquez-Malaver FJ; Sánchez-Guijo FM; Montero Cuadrado I; Ferra I Coll C; Valcárcel D; López-Godino O; Cuesta M; Parody R; López-Corral L; Alcoceba M; Caballero-Velázquez T; Rodríguez-Gil A; Bejarano-García JA; Ramos TL; Pérez-Simón JA Clin Cancer Res; 2019 Aug; 25(15):4616-4623. PubMed ID: 31043390 [TBL] [Abstract][Full Text] [Related]
10. Sphingolipid metabolism in T cell responses after allogeneic hematopoietic cell transplantation. Tian L; Ogretmen B; Chung BY; Yu XZ Front Immunol; 2022; 13():904823. PubMed ID: 36052066 [TBL] [Abstract][Full Text] [Related]
11. The Effects of Interferons on Allogeneic T Cell Response in GVHD: The Multifaced Biology and Epigenetic Regulations. Zhao C; Zhang Y; Zheng H Front Immunol; 2021; 12():717540. PubMed ID: 34305954 [TBL] [Abstract][Full Text] [Related]
12. The expanding horizon of immunotherapy in the treatment of malignant disorders: allogeneic hematopoietic stem cell transplantation and beyond. Tsirigotis P; Shimoni A; Nagler A Ann Med; 2014 Sep; 46(6):384-96. PubMed ID: 24888385 [TBL] [Abstract][Full Text] [Related]
13. The allure and peril of hematopoietic stem cell transplantation: overcoming immune challenges to improve success. Newman RG; Ross DB; Barreras H; Herretes S; Podack ER; Komanduri KV; Perez VL; Levy RB Immunol Res; 2013 Dec; 57(1-3):125-39. PubMed ID: 24272856 [TBL] [Abstract][Full Text] [Related]
14. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
15. Immunomodulatory Effects of Histone Deacetylation Inhibitors in Graft-vs.-Host Disease After Allogeneic Stem Cell Transplantation. Xu X; Li X; Zhao Y; Huang H Front Immunol; 2021; 12():641910. PubMed ID: 33732262 [TBL] [Abstract][Full Text] [Related]
16. Expanded donor natural killer cell and IL-2, IL-15 treatment efficacy in allogeneic hematopoietic stem cell transplantation. Chen G; Wu D; Wang Y; Cen J; Feng Y; Sun A; Tang X; Chang H; Zhu Z Eur J Haematol; 2008 Sep; 81(3):226-35. PubMed ID: 18573173 [TBL] [Abstract][Full Text] [Related]
17. Baricitinib-induced blockade of interferon gamma receptor and interleukin-6 receptor for the prevention and treatment of graft-versus-host disease. Choi J; Cooper ML; Staser K; Ashami K; Vij KR; Wang B; Marsala L; Niswonger J; Ritchey J; Alahmari B; Achilefu S; Tsunoda I; Schroeder MA; DiPersio JF Leukemia; 2018 Nov; 32(11):2483-2494. PubMed ID: 29691471 [TBL] [Abstract][Full Text] [Related]
18. Graft-versus-leukemia and graft-versus-host reactions after donor lymphocyte infusion are initiated by host-type antigen-presenting cells and regulated by regulatory T cells in early and long-term chimeras. Xia G; Truitt RL; Johnson BD Biol Blood Marrow Transplant; 2006 Apr; 12(4):397-407. PubMed ID: 16545723 [TBL] [Abstract][Full Text] [Related]
19. Graft-vs-leukemia activity and graft-vs-host disease induced by allogeneic Th1- and Th2-type CD4+ T cells in mice. Zeis M; Uharek L; Hartung G; Glass B; Steinmann J; Schmitz N Hematol J; 2001; 2(2):136-44. PubMed ID: 11424006 [TBL] [Abstract][Full Text] [Related]
20. Experimental and clinical approaches for optimization of the graft-versus-leukemia effect. Sprangers B; Van Wijmeersch B; Fevery S; Waer M; Billiau AD Nat Clin Pract Oncol; 2007 Jul; 4(7):404-14. PubMed ID: 17597705 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]